-
Signature
-
/s/ Xing Yan as Attorney-in-Fact for Jonathan Vassil
-
Issuer symbol
-
TOST
-
Transactions as of
-
09 May 2025
-
Net transactions value
-
-$3,906,825
-
Form type
-
4
-
Filing time
-
13 May 2025, 16:42:22 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Vassil Jonathan |
Chief Revenue Officer |
TOAST, INC., 333 SUMMER STREET, BOSTON |
/s/ Xing Yan as Attorney-in-Fact for Jonathan Vassil |
13 May 2025 |
0002004790 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
TOST |
Class A Common Stock |
Options Exercise |
$207,000 |
+100,000 |
+181% |
$2.07 |
155,220 |
09 May 2025 |
Direct |
F1 |
| transaction |
TOST |
Class A Common Stock |
Sale |
$2,897,795 |
-70,849 |
-46% |
$40.90 |
84,371 |
09 May 2025 |
Direct |
F1, F2 |
| transaction |
TOST |
Class A Common Stock |
Sale |
$1,075,897 |
-25,848 |
-31% |
$41.62 |
58,523 |
09 May 2025 |
Direct |
F1, F3 |
| transaction |
TOST |
Class A Common Stock |
Sale |
$140,133 |
-3,303 |
-5.6% |
$42.43 |
55,220 |
09 May 2025 |
Direct |
F1, F4 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
TOST |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-100,000 |
-50% |
$0.000000 |
98,996 |
09 May 2025 |
Class A Common Stock |
100,000 |
$2.07 |
Direct |
F1, F5 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: